Skip to main content
. 2023 Aug 25;11(9):852–860. doi: 10.1002/ueg2.12452

TABLE 3.

Cumulative overall mortality in Wilson's disease patients and reference individuals.

Cumulative mortality Wilson's disease patients Reference individuals
1 year 5 years 10 years 1 year 5 years 10 years
All 0.0 (−) 5.6 (2.7–11.5) 9.3 (5.0–16.8) 0.4 (0.2–0.9) 1.5 (1.0–2.3) 2.4 (1.6–3.6)
Men 0.0 (−) 6.2 (2.4–15.6) 8.6 (3.6–19.9) 0.3 (0.1–1.1) 1.5 (0.8–2.8) 1.8 (1.0–3.4)
Women 0.0 (−) 5.1 (1.7–15.0) 10.0 (4.2–22.7) 0.6 (0.2–1.5) 1.4 (0.7–2.7) 3.1 (1.8–5.2)
Age <20 years 0.0 (−) 0.0 (−) 0.0 (−) 0.0 (−) 0.2 (0.0–1.6) 0.2 (0.0–1.6)
Age ≥20 years 0.0 (−) 8.1 (3.9–16.2) 12.7 (7.0–22.5) 0.6 (0.3–1.4) 2.1 (1.3–3.3) 3.3 (2.2–5.0)
Wilson's disease, born in Sweden 0 (−) 5.6 (2.4–12.9) 10.8 (5.4–20.9) 0.3 (0.1–1.0) 1.5 (0.9–2.5) 2.5 (1.5–4.0)
Wilson's disease, born outside Sweden 0 (−) 5.8 (1.5–21.5) 5.8 (1.5–21.5) 0.7 (0.2–2.0) 1.5 (0.7–3.2) 2.3 (1.1–4.8)
Neuropsychiatric condition 0 (−) 12.5 (5.4–27.5) 20.7 (10.0–39.7) 0.6 (0.2–1.9) 1.7 (0.8–3.6) 3.5 (1.9–6.4)
No neuropsychiatric condition 0 (−) 2.4 (0.6–9.3) 4.1 (1.3–12.3) 0.3 (0.1–1.0) 1.4 (0.8–2.4) 2.0 (1.2–3.4)

Note: Results are in per cent.